<--- Back to Details
First PageDocument Content
Ribbon symbolism / Trastuzumab / Adjuvant therapy / Breast cancer / Management of cancer / End point of clinical trials / Triple-negative breast cancer / Neoadjuvant therapy / MammaPrint / Medicine / Cancer treatments / Oncology
Date: 2012-10-18 15:17:39
Ribbon symbolism
Trastuzumab
Adjuvant therapy
Breast cancer
Management of cancer
End point of clinical trials
Triple-negative breast cancer
Neoadjuvant therapy
MammaPrint
Medicine
Cancer treatments
Oncology

The NEW ENGLA ND JOURNAL of

Add to Reading List

Source URL: fnih.org

Download Document from Source Website

File Size: 388,78 KB

Share Document on Facebook

Similar Documents

Clinical medicine / Cancer / Medicine / RTT / Ribbon symbolism / Breast cancer / Adjuvant therapy / Aromatase inhibitor / Oncotype DX / MammaPrint

Prediction of 10-year distant recurrence (DR) using the Prosigna® (PAM50) test in a Danish Breast Cancer Cooperative Group (DBCG) cohort of postmenopausal Danish women with hormone receptor-positive (HR+) early breast c

DocID: 1qXDq - View Document

Medicine / Clinical medicine / RTT / Pathology / Ribbon symbolism / Breast cancer / Cancer / Biopsy / Medical laboratory / Medicare / MammaPrint / Breast cancer management

Biotheranostics • 9640 Towne Centre Dr., Suite 200 • San Diego, CA 92121, USA Toll Free: ( • Fax: ( • www.Biotheranostics.com Test Requisition Form ORDERING INSTRUCTIONS

DocID: 1qj4l - View Document

Clinical research / Pharmaceutical industry / Design of experiments / Drug discovery / Medical statistics / Clinical trial / Drug development / Patient recruitment / Phases of clinical research / Placebo / Quality of life / MammaPrint

Decision-theoretic designs for small trials and pilot studies: A review

DocID: 1p6UO - View Document

Aromatase inhibitors / Progonadotropins / RTT / Ribbon symbolism / Letrozole / Triazoles / Breast cancer / Tamoxifen / Radiation therapy / MammaPrint

Microsoft Word - SOLE protocol V1.2 06Jul07.doc

DocID: 1oHrK - View Document

Ribbon symbolism / Gynaecological cancer / Biomarkers / Personalized medicine / Breast cancer / Ovarian cancer / MammaPrint / Cross-validation / Data mining / Medicine / Biology / Genetics

Shorter multimarker signatures: a new tool to facilitate cancer diagnosis Abstract 667 M. P. Schneider, N. Jullian, M. Afshar, M. Guergova-Kuras

DocID: 19ZKP - View Document